Yahoo News8h
The FDA Initiated a Class III Recall on More Than 150,000 Bottles of Water
Food & Wine / Getty Images The U.S. Food and Drug Administration (FDA) is recalling 151,397.75 bottles of water due to ...
Even if RFK Jr. fires everyone at the FDA, if won’t matter because he doesn’t know anyone with the ‘technical expertise’ to alter the rules, former chief counsel says
Donald Trump has tapped vaccine-skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
MedPage Today3h
Clozapine's REMS Program on the Chopping Block at Upcoming FDA Meeting
"Severe neutropenia occurs in a small percentage of patients taking clozapine; however, neutropenia is associated with an ...
McDonald's Onion Recall Update as FDA Sets Highest Risk Level
The FDA has issued a Class I risk classification for a large number of recalled onions produced by Taylor Farms.
Opinion - Is the FDA contributing to the homelessness crisis?
The FDA's REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...
STAT15h
FDA commissioner: We need action and higher-quality research on ultra-processed foods
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...
Becker's Hospital Review5h
FDA warns of arterial bypass device safety concerns: 5 things to know
The FDA has warned providers of safety concerns and supply issues for Getinge/Maquet's VasoView HemoPro Endoscopic Vessel Harvesting Systems. The device is primarily used during endoscopic arterial ...
New FDA rules for TV drug ads: Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
Cure Today3h
FDA Approves Revuforj for Relapsed/Refractory Acute Leukemia Subset
Revuforj was approved by the FDA for adults and children with relapsed/refractory acute leukemia with a KMT2A translocation.